Ferrokin Biosciences
Latest round
- Series B
Last raised
- Jun 2010
Total raised
- $27M
Investors
- 5
About Ferrokin Biosciences
Ferrokin Biosciences Inc specializes in the development of therapies aimed at treating iron overload conditions. Founded in San Carlos, US, the company has navigated a significant change in strategy, leading to its acquisition by Shire PLC in March 2012 for USD 325 mn, which included an upfront payment of USD 100 mn. The firm has engaged in a total of 6 deals, with the latest deal finalized on March 15, 2012.Ferrokin Biosciences Inc concentrates on the research and development of therapies specifically designed to address iron overload disorders. Their product pipeline includes innovative treatments that utilize advanced drug delivery systems, enhancing the efficacy and safety of iron chelation therapy.Ferrokin Biosciences Inc generates revenue through the commercialization of its therapeutics for iron overload diseases. The company's focus is on direct sales from their product offerings, supplemented by partnerships with healthcare providers and institutions that facilitate broader access to their therapies.Ferrokin Biosciences Inc is focused on expanding its product line with new therapies designed to improve the management of iron overload disorders, with planned launches in the next few years. The company aims to increase its market presence, particularly in the US and European regions, seeking to establish a foothold in additional international markets by 2025. The recent acquisition by Shire PLC will provide the necessary resources to support these strategic growth initiatives and further enhance their research capabilities.
Who invested in Ferrokin Biosciences
5 investors across 3 rounds
See all investors in Ferrokin Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ferrokin Biosciences
Who invested in Ferrokin Biosciences?
Ferrokin Biosciences has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ferrokin Biosciences raised?
Ferrokin Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Ferrokin Biosciences last raise money?
Ferrokin Biosciences's most recent round on record is a Series B, in Jun 2010.
What does Ferrokin Biosciences do?
Ferrokin Biosciences Inc specializes in the development of therapies aimed at treating iron overload conditions.
Where is Ferrokin Biosciences headquartered?
Ferrokin Biosciences is headquartered in San Carlos, US.
Which VCs invest in companies like Ferrokin Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ferrokin Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Ferrokin Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.